Dai Yichen, Cui Xiaolin, Zhang Ge, Mohsin Ali, Xu Huiming, Zhuang Yingping, Guo Meijin
State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, 130 Meilong Rd., P.O. box 329#, Shanghai, 200237 China.
Christchurch Regenerative Medicine and Tissue Engineering (CReaTE) Group, Department of Orthopaedic Surgery & Musculoskeletal Medicine, University of Otago, Christchurch, 8011 New Zealand.
Cytotechnology. 2022 Jun;74(3):351-369. doi: 10.1007/s10616-022-00523-5. Epub 2022 Mar 10.
Human umbilical cord mesenchymal stem/stromal cells (hUC-MSCs) have attracted significant research interests in regenerative medicine and cell-based therapies due to their minimally invasive isolation procedure, abundant availability, allogenic nature, improved proliferation capacity and tri-lineage differentiation potential. However, the challenge in harvesting a sufficient number of hUC-MSCs through conventional static culture for downstream application hinders the downstream clinical translation of hUC-MSCs. Hence, an alternative culture method that can facilitate large-scale expansion is highly desirable. Herein, we developed a microcarrier-based dynamic culture system to culture hUC-MSCs combined fed-batch mode with medium refreshment to decrease concentrations of metabolic wastes, improve nutrient supplement and reduce the amount of medium used for cell culture. Instead of refreshing medium based on the pre-determined frequency, the replacement and feeding of medium using the novel feeding regime were carried out based on consumption of nutrients (glucose and glutamine) and production of metabolic waste (lactate and ammonia) to maintain a balanced and benign culture microenvironment. The optimal process allowed over 20 folds increase of cell with a maximum cell density at (24.13 ± 0.59) × 10 cells/mL. In addition, no significant alteration of cell surface markers of hUC-MSCs derived from dynamic conditions was observed compared to static conditions. Impressively, over 99.8% of the cellular population showed the desired positive expression of CD73, CD90 and CD105, while less than 0.2% of the population showed undesired negative expression of CD34, CD45 and HLA-DR. More importantly, hUC-MSCs derived from our dynamic culture condition still maintained their trilineage differentiation capacity.
The online version contains supplementary material available at 10.1007/s10616-022-00523-5.
人脐带间充质干细胞(hUC-MSCs)因其微创分离程序、丰富的来源、同种异体性质、增强的增殖能力和三系分化潜能,在再生医学和基于细胞的治疗中引起了广泛的研究兴趣。然而,通过传统静态培养收获足够数量的hUC-MSCs用于下游应用面临挑战,这阻碍了hUC-MSCs的下游临床转化。因此,迫切需要一种能够促进大规模扩增的替代培养方法。在此,我们开发了一种基于微载体的动态培养系统,将补料分批培养模式与培养基更新相结合,以降低代谢废物浓度、改善营养补充并减少细胞培养所用培养基的量。与基于预定频率更新培养基不同,使用新型补料方式进行培养基的更换和补料是基于营养物质(葡萄糖和谷氨酰胺)的消耗以及代谢废物(乳酸和氨)的产生,以维持平衡且良性的培养微环境。最佳工艺使细胞增加了20倍以上,最大细胞密度达到(24.13±0.59)×10⁶个细胞/mL。此外,与静态培养条件相比,未观察到动态培养条件下hUC-MSCs的细胞表面标志物有显著变化。令人印象深刻的是,超过99.8%的细胞群体显示出CD73、CD90和CD105的预期阳性表达,而不到0.2%的群体显示出CD34、CD45和HLA-DR的非预期阴性表达。更重要的是,我们动态培养条件下获得的hUC-MSCs仍保持其三系分化能力。
在线版本包含可在10.1007/s10616-022-00523-5获取的补充材料。